Home > About GAMMAGARD LIQUID > What to Expect

GAMMAGARD LIQUID for SubQ Administration

SubQ administration of GAMMAGARD LIQUID treatment is another administration option available to you. Based on your ability, lifestyle, and preference, you can work with your healthcare provider to decide which administration option is right for you.

What to Know About SubQ Treatment

  • GAMMAGARD LIQUID SubQ infusions are delivered under your skin through
    1 or more (maximum of 8 simultaneous sites) needles inserted in the upper arms, abdomen, thighs, or lower back.1
  • Ig treatment is absorbed into your bloodstream through the tissues beneath your skin.1,2
  • SubQ administration may be administered by yourself or a caregiver at home, once a week.1
  • Before you start infusing at home, a nurse will train you or your caregiver to make sure you know what you're doing and feel comfortable doing it.
  • The number of sites depends on your dose. In the clinical study (N=47) of SubQ administration of GAMMAGARD LIQUID SubQ, weekly infusion times ranged from 0.8 to 2.3 hours (the weekly median infusion time was 1.2 hours).

What to Expect With SubQ Treatment

Before the infusion:

  • Choose a quiet time of day
  • Take precautions to avoid disruptions while infusing
  • Set up supplies1
  • Select a book, movie, or other relaxing activity to occupy yourself during the infusion
  • It is recommended that you have another responsible person at home while self-infusing in case you experience a side effect1

During the infusion:

  • Relax comfortably when using an ambulatory or mobile infusion pump
  • Care for any reactions as instructed by your healthcare provider2

After the infusion:

References: 1. GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% [Prescribing Information]. Westlake Village, CA: Baxalta US Inc. 2. Younger MEM, ed. IDF Guide for Nurses: Immunoglobulin Therapy for Primary Immunodeficiency Diseases. 4th ed. Towson, MD: Immune Deficiency Foundation; 2016.

Gammagard Liquid MyIgCoPayCard Program Terms and Conditions

This manufacturer's coupon program is not valid for prescriptions reimbursed, in whole or in part, by Medicaid, Medicare, Medigap, VA, DoD, TRICARE, or any other federal or state healthcare programs, including state pharmaceutical assistance programs, and where prohibited by the health insurance provider or by law

Shire's MyIgCoPayCard program provides a maximum total benefit of $5,000 for eligible out-of-pocket costs and expires 12 months from date of activation. Eligible costs include deductible, copayment, and co-insurance costs for eligible Shire IG (Immunoglobulin) products. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible.

To be eligible, patients must: 1. be starting or receiving treatment with (and have current prescription for) an eligible Shire IG product with an ICD-10 for a diagnosis of Primary Immunodeficiency; and 2. have commercial insurance that covers medication costs for prescribed Shire IG product and allows for CoPay assistance; and 3. be two (2) years old or older.

Acceptance of this offer must be consistent with the terms of benefits provided by patient's health insurance provider.

Offer limited to one card per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, or other offer.

This program is only valid for residents of the United States.

Shire reserves the right to change or discontinue this program at any time without notice.

This is not health insurance.


Add to patient instructions:

If your insurance situation changes, it is your responsibility to notify MyIgSource's CoPay assistance program.

© 2017 Shire. All rights reserved.

SHIRE and the Shire Logo are registered trademarks of Shire Pharmaceutical Holdings Ireland Limited or its affiliates. Gammagard Liquid is a trademark or registered trademark of Baxalta Incorporated, a wholly owned, indirect subsidiary of Shire plc.

S30515 04/17

Please expand for Indication and Important Safety Information.


What is the most important information that I should know about GAMMAGARD LIQUID?

GAMMAGARD LIQUID can cause the following serious reactions: severe allergic reactions causing difficulty in breathing or skin rashes; decreased kidney function or kidney failure; blood clots in the heart, brain, lungs or elsewhere in the body; severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting; dark colored urine, swelling, fatigue, or difficulty breathing.